|
Gastrointestinal |
Nausea, vomiting, epigastric distress, abdominal cramping, diarrhea,
constipation, mesenteric arterial thrombosis, and ischemic colitis |
|
Neurological |
Light-headedness, mental depression manifested by insomnia, lassitude,
weakness, fatigue; reversible mental depression progressing to catatonia;
visual disturbances; hallucinations; vivid dreams; an acute reversible
syndrome characterized by disorientation for time and place, short-term
memory loss, emotional lability, slightly clouded sensorium, and decreased
performance on neuropsychometrics, fatigue, lethargy, and vivid dreams |
|
Cardiac |
Bradycardia; congestive heart failure; intensification of AV block;
hypotension; paresthesia of hands; thrombocytopenic purpura; arterial
insufficiency, Raunaud’s |
|
Skin |
Alopecia, LE-like reactions, psoriasiform rashes |
|
Hematologic |
Agranulocytosis, nonthrombocytopenic purpura, and thrombocytopenic purpura
Pulmonary |
|
Pulmonary |
Bronchospasm. |
|
Systemic |
Pharyngitis and agranulocytosis, erythematous rash, fever combined with
aching and sore throat, laryngospasm, and respiratory distress, dry
eyes, male impotence, and Peyronie's disease have been reported rarely.
Oculomucocutaneous reactions involving the skin, serous membranes, and
conjunctivae reported for a beta blocker (practolol) have not been
associated with propranolol. |
|